RhumbLine Advisers
TSHA icon

RhumbLine Advisers’s Taysha Gene Therapies TSHA Stock Holding History

RhumbLine Advisers’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$539K Buy
2025
Q1 		$286K Buy
2024
Q4 		$332K Buy
2024
Q3 		$374K Buy
2024
Q2 		$413K Buy
2022
Q2 		– Sell
2022
Q1 		$146K Buy
2021
Q4 		$230K Sell
2021
Q3 		$375K Buy
2021
Q2 		$396K Buy